Granules India Limited is a well-known pharmaceutical company with a strong presence in APIs, intermediates, and finished dosage formulations. With continuous capacity expansion, focus on regulated markets like the US and Europe, and a growing product portfolio, the company is steadily strengthening its business foundation.
Investors closely track the Granules share price target for 2026, 2027, 2028, 2029, and 2030 to understand how long-term growth, improving margins, and global demand for generic medicines may shape its future valuation.
Granules Share Price Target 2026
Granules India Limited is a well-established pharmaceutical company known for its strong presence in active pharmaceutical ingredients (APIs) and finished dosage formulations, supplying to major global markets.
The company’s focus on backward integration, cost efficiency, and expansion into high-margin products supports its long-term growth outlook. With rising demand for generic medicines and improving operating margins, Granules is expected to deliver steady financial performance.
Based on current business trends and growth prospects, the Granules share price target for 2026 is estimated to be in the range of ₹600 to ₹630. However, actual performance may vary depending on market conditions, regulatory approvals, and global pharma demand.
Granules Share Price Target 2026 Table
| Year | Granules Share Price Target 2026 |
|---|---|
| First Target 2026 | Rs 600 |
| Second Target 2026 | Rs 630 |
Granules Share Price Target 2027
Granules India Limited continues to strengthen its position in the pharmaceutical sector with a strong focus on API manufacturing, finished dosages, and global market expansion.
The company’s growing presence in regulated markets like the US and Europe, along with capacity expansion and backward integration, supports long-term growth visibility.
Based on current business momentum and industry outlook, the Granules share price target for 2027 is expected to be in the range of ₹650 to ₹680. Stable demand for generic medicines, improving margins, and operational efficiency could act as key catalysts for the stock. However, overall market conditions and regulatory developments will also play an important role in shaping future performance.
Granules Share Price Target 2027 Table
| Year | Granules Share Price Target 2027 |
|---|---|
| First Target 2027 | Rs 650 |
| Second Target 2027 | Rs 680 |
Granules Share Price Target 2028
Granules India continues to strengthen its position in the pharmaceutical sector with a strong focus on APIs, formulations, and growing exports to regulated markets like the US and Europe.
The company’s consistent capacity expansion, cost efficiency, and improving product mix support long-term growth prospects. Backed by healthy demand for generic medicines and stable financial performance, Granules remains attractive for long-term investors.
Based on current growth trends and industry outlook, the Granules share price target for 2028 is expected to range between ₹720 (conservative target) and ₹750 (optimistic target), depending on earnings growth and market conditions.
Granules Share Price Target 2028 Table
| Year | Granules Share Price Target 2028 |
|---|---|
| First Target 2028 | Rs 720 |
| Second Target 2028 | Rs 750 |
Granules Share Price Target 2029
Granules India continues to attract investor interest due to its strong presence in the pharmaceutical API and finished dosage segments, along with a growing global footprint.
The company’s focus on backward integration, capacity expansion, and operational efficiency is expected to support steady earnings growth over the long term. With increasing demand for affordable generic medicines in key markets like the US and Europe, Granules is well-positioned for sustainable growth.
Based on current fundamentals and long-term growth prospects, the Granules share price target for 2029 is estimated to be in the range of ₹780 to ₹820. These targets may vary depending on market conditions, regulatory developments, and overall pharma sector performance.
Granules Share Price Target 2029 Table
| Year | Granules Share Price Target 2029 |
|---|---|
| First Target 2029 | Rs 780 |
| Second target 2029 | Rs 820 |
Granules Share Price Target 2030
Granules India Limited is a well-established pharmaceutical company with a strong presence in APIs, pharmaceutical formulation intermediates, and finished dosages, catering to both domestic and global markets.
Driven by capacity expansion, focus on high-margin products, and long-term contracts with global pharma majors, the company is expected to maintain steady growth. Improving operational efficiency and a healthier balance sheet further strengthen its long-term outlook.
Considering these factors, the Granules share price target for 2030 is estimated to be in the range of ₹850 to ₹880, assuming stable market conditions and consistent earnings growth.
Granules Share Price Target 2030 Table
| Year | Granules Share Price Target 2030 |
|---|---|
| First Target 2030 | Rs 850 |
| Second Target 2030 | Rs 880 |
Granules Share F.A.Q.
– What does Granules India do?
Granules India is a pharmaceutical company that manufactures active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), and finished dosage medicines. It mainly focuses on high-volume, low-cost generic drugs.
– Is Granules Share good for long-term investment?
Granules share attracts long-term investors due to its strong export business and growing product portfolio. However, stock performance depends on market trends, financial results, and industry competition.
– What factors affect Granules Share price?
Granules share price is influenced by company earnings, USFDA approvals, global demand for generic medicines, and raw material costs. Market sentiment and pharma sector growth also impact the stock.
– Does Granules India pay dividends?
Yes, Granules India has a history of paying dividends to its shareholders. The dividend amount may vary depending on company profits and future expansion plans.
Conclusion
Looking ahead, Granules India’s long-term outlook appears promising, supported by its integrated business model, strong export focus, and increasing emphasis on value-added formulations. If the company continues to execute well on product launches, regulatory compliance, and cost efficiency, Granules share price targets from 2026 to 2030 could see gradual and sustainable growth. As always, investors should align these projections with their risk profile and keep an eye on market conditions and company fundamentals before making investment decisions.
Also read:-